Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03800069 · ClinicalTrials.gov registry record
Validation of Point of Care Liver Function Tests
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 68
- Enrollment target
NCT03800069: Clinical Trial study, sponsored by University of Pennsylvania.
NCT03800069 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03800069 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 68 participants
- Enrollment target
Study Summary
This study is testing the accuracy of a point of care device that tests liver function within 20 minutes. The target population will be any adult who had liver function tests ordered and to be drawn on the same day as enrollment.
Primary Outcome
Each data point will represent one observation or one test run. The investigators will use regression methods to determine the linear relationship between standard lab results and Group K diagnostic's device.
Interventions
- DEVICE Group K Diagnostic point of care device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2018-12-03 |
| Est. Completion | 2019-05-30 |
Why NCT03800069 stopped before completion
NCT03800069 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Group K Diagnostic point of care device is the first listed.
NCT03800069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03800069 about?
NCT03800069 is a clinical study titled "Validation of Point of Care Liver Function Tests". This study is testing the accuracy of a point of care device that tests liver function within 20 minutes. The target population will be any adult who had liver function tests ordered and to be drawn on the same day as enrollment.
What is the current status of trial NCT03800069?
This trial is currently terminated. The enrollment target is 68 participants. The study started on 2018-12-03. Estimated completion is 2019-05-30.
What interventions are being tested in trial NCT03800069?
The interventions under investigation include: Group K Diagnostic point of care device (DEVICE).
Who is sponsoring clinical trial NCT03800069?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI